Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors
Author:
Publisher
Wiley
Subject
Oncology,Hematology,Pediatrics, Perinatology, and Child Health
Reference15 articles.
1. High-Dose Melphalan, Etoposide, Total-Body Irradiation, and Autologous Stem-Cell Reconstitution as Consolidation Therapy for High-Risk Ewing’s Sarcoma Does Not Improve Prognosis
2. Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors
3. Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies
4. High-Dose Therapy for Patients With Primary Multifocal and Early Relapsed Ewing’s Tumors: Results of Two Consecutive Regimens Assessing the Role of Total-Body Irradiation
5. , , et al. Autologous bone marrow transplantation in Ewing's sarcoma: An analysis of phase II studies from the European Bone Marrow Transplantation Group. Proc Fourth Int Symp autologous Bone Marrow Transplant 1988; 39: 593–599.
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents;Pediatric Drugs;2023-04-04
2. Prognostic and therapeutic factors influencing the clinical outcome of metastatic Ewing sarcoma family of tumors: A retrospective report from the Japan Ewing Sarcoma Study Group;Pediatric Blood & Cancer;2020-12-19
3. Pazopanib maintenance therapy after tandem high-dose chemotherapy for disseminated Ewing sarcoma;International Cancer Conference Journal;2019-02-14
4. Infectious Complications during Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Children with High-Risk or Recurrent Solid Tumors;PLOS ONE;2016-09-14
5. High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas;Journal of Korean Medical Science;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3